A116S (p.Ala116Ser) variant of SLC35A2 (UDP-galactose translocator)

A116S (p.Ala116Ser) in SLC35A2 (UDP-galactose translocator) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact in the context of in CDG2M. The available variant effect predictions contribute to a CATVariant prioritization score of 0.40 / 1. The record also includes population frequency data and structural context.

A116S (p.Ala116Ser) variant details